NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
Back to search
Official data from USPTO
CENCORA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/12/2026
Trademark type
Combined
Nice classes
42
Filing date
12/26/2023
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-11-00
First use in commerce
2024-11-00
Drawing code
5
Owner type
03
Owner location
Conshohocken, PA, US
Examiner
GANESH, HARINI
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "CENCORA".
Holders and representatives
Holders
Cencora, Inc.
Representatives
Anita B. Polott Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesresearch and design in the field of new product design and scientific research in the field of pharmacovigilanceclinical data reviewchemistry data evaluation; Scientific research and laboratory researchall in the field of pharmaceuticalsmedicines and medical products; industrial analysis and research serviceslaboratory research services relating to pharmaceuticalspharmaceutical research servicesresearch and development of new products for others; consulting services for others in the field of designplanningimplementation project management in the field of pharmaceuticalsmedicines and medical products; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing of materials; pharmaceutical products development; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; information technology services for the pharmaceutical and healthcare industriesinformation technology consulting services relating to computer network designcomputer software designinformation technology architecture and infrastructureinstallationmaintenance and repair of computer software; quality control testing for others; materials testing and evaluation; product safety testing; consulting services for others in the field of designplanningimplementation project management of clinical trials; providing medical and scientific research information in the fields of pharmaceuticalsdrug safetyclinical researchclinical testing and clinical trials; Scientific and technological servicesresearch and design in the field of pharmaceutical developmentmedical devicesbiopharmaceuticals; scientifictechnologicalmedical and pharmaceutical research and development services; industrial analysis and research services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientifictechnologicalmedical research and pharmaceutical research services and analysis services for scientific and technological purposes; biological research; clinical researchscientific research in the nature of conducting clinical trials for others; providing medical research and scientific research information; provision of scientific information in the nature of scientific surveys; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticalsvaccinesmedicinebiologicsbiotherapeuticsbiosimilarstherapeutics; development of a web application software for entering and evaluating informative texts for pharmaceuticals and medical productsin particular instructions for usepackage insertsspecialist information and for the provision of various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; testinginspection or research of pharmaceuticals and medicines; designengineeringresearchdevelopment and testing services in the field of pharmaceuticalsmedical devicesbiopharmaceuticals; research in the field of gene therapy; consultancy relating to quality assurance servicesquality assurancequality controlquality evaluation and analysis in the field of pharmaceuticalspharmaceutical manufacturingmedical devicesbiopharmaceuticals; research services relating to scientific work; preparation of scientific research analyses and evaluations relating to pharmaceuticalsmedical devicesbiopharmaceuticals; development of pharmaceutical preparations and medicines; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; computer serviceson-site management of information technology systems for the pharmaceutical and healthcare industries; scientific evaluation of the drugs of others to determine drug efficacy; research and development services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design for others; analysis and evaluation of product development for others; quality control and evaluation of goods of others to determine conformity with certification standards; quality testing of products for certification purposes; consulting and advice on drug safety and monitoring for product research and development purposes; consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose; consultancy services for others in the field of designplanningimplementation and project management of clinical trialsscientific pharmacovigilance researchpharmaceutical and biotechnology product development; consultancy services in the fields of biotechnologypharmaceutical research and developmentlaboratory testing of materials and pharmacogenetics; research laboratory analysis service in the field of pharmaceuticals and biotechnology product development relating to the diagnosis and treatment of persons; Software as a service (SAAS) services featuring software for product development processes and regulatory compliance using artificial intelligence for supporting decision making processes; Software as a service (SAAS) services featuring software for supporting decision making processes; Software as a service (SAAS) services featuring software for collecting data related to clinical trialsdrug developmentdrug safety; Software as a service (SAAS) servicesautomation software for collecting data related to clinical trialsdrug developmentdrug safety; providing online non-downloadable computer programs for data processing; providing online non-downloadable unified communications software for integrating communications systems and tools; providing online non-downloadable assistive software for collecting data related to clinical trialsdrug developmentdrug safety
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/21/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/07/2026
IUAF
USE AMENDMENT FILED
10/20/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/20/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/22/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/22/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/22/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/22/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/03/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08/29/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
08/29/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/05/2024
GNRT
NON-FINAL ACTION E-MAILED
06/05/2024
CNRT
NON-FINAL ACTION WRITTEN
06/05/2024
DOCK
ASSIGNED TO EXAMINER
05/28/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2024
NWAP
NEW APPLICATION ENTERED
12/26/2023
Continuous trademark protection
Get notified about every new filing that threatens CENCORA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.